2Cai HB, Ding XH, Zhou YF, et al. Risk factors for cervical cancer in China: a case-control study[ J ]. Eur J Gynaecol Oncol ,2008,29( 1 ) :72-75.
3Centers for Disease Control and Prevention. Sexually transmitted diseases[J]. Treatment Guidelines, 2006,55:62-66.
4Hernandez-Giron, Carlos MD, Msc K, et al. High- risk human papillomavirus detection and prelated risk factors among pregnant and nonpregnant women in Mexico[ J ]. Sexually Transmitted Dis,2005,32(10) :613-618.
5Yang BH,Bray FI,Parkin DM,et al.Cervical cancer as a priority for prevention in different world regions:an evaluation using years of life lost[J].Int J Cancer,2004,109:418-424.
6Parkin DM,Bray F,Ferlay J,et al.Global Cancer Statistics,2002[J].CA:A Cancer Journal for Clinicians,2005,55:74-108.
7Sood AK,Sorosky JI,Mayr N,et al.Cervical cancer diagnosed shortly after pregnancy,prognostic variables and delivery routes[J].Obstet Gynecol,2000,95(6):832-838.
8Limaye A,Connor AJ,Huang X,et al.Comparative analysis of conventional Papanicolaou tests and a fluid-based thin-layer method.Arch Pathol Lab Med,2003,127:200-204.
9Diaz-Rosario LA,Kabawat SE.Performance of a fluid-based,thin-layer papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England.Arch Pathol Lab Med,1999,123:817-821.
10National Cancer Institute.The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses.National Cancer Institute Workshop.JAMA,1989,262:931-934.
